RecruitingPhase 2NCT05514340

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pharmazz, Inc.
Principal Investigator
Anil Gulati, MD
Chairman and CEO
Intervention
Normal Saline along with standard treatment(drug)
Enrollment
40 target
Eligibility
All sexes
Timeline
20232026

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05514340 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials